BALCHEM CORP is 2.2x more valuable than Ingevity Corp by market capitalization ($5.19 B vs $2.37 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BCPC | NGVT |
|---|---|---|
| Market cap | $5.19 B | $2.37 B |
| US-listed rank | #1359 | #1977 |
| Revenue (latest FY) | $1.04B | $1.17B |
| Net income (latest FY) | $154.85M | -$167.10M |
| Net margin | 14.9% | -14.3% |
| P/E (trailing FY) | 33.5 | - |
| SEC filings | 1,267 | 636 |
BALCHEM CORP is 2.2x more valuable than Ingevity Corp by market capitalization ($5.19 B vs $2.37 B).
In their latest fiscal years, BALCHEM CORP reported $1.04B in revenue while Ingevity Corp reported $1.17B.
Full pages: BALCHEM CORP and Ingevity Corp, or browse the full rankings.